NCT05175222 is a NA clinical trial of Laser therapy in Oral Mucositis, sponsored by Medical University of Gdansk.

Who is sponsoring NCT05175222?

NCT05175222 is sponsored by Medical University of Gdansk.

What drugs are being tested in NCT05175222?

Interventions in NCT05175222: Laser therapy.

What condition does NCT05175222 study?

NCT05175222 studies Oral Mucositis, Bone Marrow Transplant Complications.

Is NCT05175222 still recruiting?

NCT05175222 is currently completed. Last updated 3 January 2022.

Last reviewed 2022-01-03 · How we verify

NCT05175222

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Efficacy of LightWalker (Nd:Yag, Er:Yag) Laser Therapy on Incidence, Severity and Duration of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT). Prospective Randomized Open-label Study

Completed NA Last updated 3 January 2022

What this trial tests

NA trial testing Laser therapy in Oral Mucositis in 40 participants. Completed in 11 December 2020.

Timeline

1 January 2019

Primary endpoint
31 December 2019

11 December 2020

Quick facts

Lead sponsor	Medical University of Gdansk
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	40
Start date	1 January 2019
Primary completion	31 December 2019
Estimated completion	11 December 2020
Sites	1 location across Poland

Drugs / interventions tested

Laser therapy

Conditions studied

Oral Mucositis — all drugs for Oral Mucositis →
Bone Marrow Transplant Complications — all drugs for Bone Marrow Transplant Complications →

Sponsor

Medical University of Gdansk

Who can join

18 and older, any sex, with Oral Mucositis or Bone Marrow Transplant Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oral mucositis (OM) is a common and debilitating adverse effect of conditioning regimens in patients undergoing hematopoietic cell transplantation (HCT). It is treated symptomatically with pain relief medications. The use of low-level laser therapy (LLLT) to prevent tissue damage has been postulated for almost forty years, however, there are only a few reports concerning old generation lasers in mucositis prophylaxis in HCT recipients. Here we hypothesized, that a new generation LLLT (Nd: YAG Fotona LightWalker®) laser may be an effective prophylaxis in shortening and reducing the severity of this complication.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Laser therapy

Trials testing the same drug.

NCT06330363 — The Impact of Low Level Laser Treatment on Skeletal Muscle and Skin Tissue · NA · completed
NCT06428851 — Laser Therapy Versus Neuromuscular Electrical Nerve Stimulation at Hemiplegic Shoulder Pain · NA · completed
NCT06865508 — Photo Biomodulation Therapy for Alveolar Osteitis Recovery in Oral Contraceptive Users · NA · completed
NCT06267417 — Laser Therapy Effect as Preventive Measure for Oral Mucositis in Children With Hematological Malignancies · NA · completed
NCT03995797 — VESPER: Pelvic Organ Prolapse Study · NA · withdrawn

Other recruiting trials for Oral Mucositis

Currently open trials in the same condition.

NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
NCT07400328 — Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients · Phase 2 · recruiting
NCT06525402 — Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on Degree of Oral Mucositis in Children Receiving Chemothe · NA · recruiting
NCT06315855 — F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors) · NA · recruiting
NCT05966194 — RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer · Phase 2 · recruiting

Other Medical University of Gdansk trials

Trials by the same sponsor.

NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05175222 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
Last refreshed: 3 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05175222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing